• Jump to main navigation
  • Jump to content
U of U Health
  • Find A Doctor Find A U of U Health Doctor
  • Services All U of U Health Services
  • Locations All U of U Health Locations
  • For Patients & Visitors For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart

Perkins, Sherrie L., MD, PhD

Vice-Chair, Department of Pathology

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English, French

Dr. Perkins, MD, PhD, is the CEO of ARUP Laboratories and a Professor of Pathology at the University of Utah, School of Medicine. Dr. Perkins has been with ARUP and the University of Utah for over 25 years; during this time, she has served in numerous leadership roles, including Director of Hematopathology, Interim Department Chair, Division Chief of Clinical Pathology, Director of the ARUP R&D Institute, and, for the past ten years, member of the ARUP Laboratories' executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology, and holds a special qualification in hematology. She has authored over 190 peer-reviewed journal articles and 40 book chapters in hematopathology. She received her PhD in biochemistry from the University of Miami, and earned her MD and completed her pathology residency at Washington University in St. Louis. She completed her hematopathology fellowship under Dr. Carl Kjeldsberg at the University of Utah.

Dr. Perkins, MD, PhD, is the CEO of ARUP Laboratories and a Professor of Pathology at the University of Utah, School of Medicine. Dr. Perkins has been with ARUP and the University of Utah for over 25 years; during this time, she has served in numerous leadership roles, including Director of Hematopathology, Interim Department Chair, Division Chief of Clinical Pathology, Director of the ARUP R&D Institute, and, for the past ten years, member of the ARUP Laboratories' executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology, and holds a special qualification in hematology. She has authored over 190 peer-reviewed journal articles and 40 book chapters in hematopathology. She received her PhD in biochemistry from the University of Miami, and earned her MD and completed her pathology residency at Washington University in St. Louis. She completed her hematopathology fellowship under Dr. Carl Kjeldsberg at the University of Utah.

Specialties

  • Hematopathology
  • Pathology

Board Certification and Academic Information

Academic Departments Pathology - Professor
Pediatrics - Adjunct Professor
Academic Divisions Clinical Pathology
Pediatric Administration
Board Certification American Board of Pathology (Sub: Anatomic Path)
American Board of Pathology (Sub: Hematology)

Dr. Perkins, MD, PhD, is the CEO of ARUP Laboratories and a Professor of Pathology at the University of Utah, School of Medicine. Dr. Perkins has been with ARUP and the University of Utah for over 25 years; during this time, she has served in numerous leadership roles, including Director of Hematopathology, Interim Department Chair, Division Chief of Clinical Pathology, Director of the ARUP R&D Institute, and, for the past ten years, member of the ARUP Laboratories' executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology, and holds a special qualification in hematology. She has authored over 190 peer-reviewed journal articles and 40 book chapters in hematopathology. She received her PhD in biochemistry from the University of Miami, and earned her MD and completed her pathology residency at Washington University in St. Louis. She completed her hematopathology fellowship under Dr. Carl Kjeldsberg at the University of Utah.

Dr. Perkins, MD, PhD, is the CEO of ARUP Laboratories and a Professor of Pathology at the University of Utah, School of Medicine. Dr. Perkins has been with ARUP and the University of Utah for over 25 years; during this time, she has served in numerous leadership roles, including Director of Hematopathology, Interim Department Chair, Division Chief of Clinical Pathology, Director of the ARUP R&D Institute, and, for the past ten years, member of the ARUP Laboratories' executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology, and holds a special qualification in hematology. She has authored over 190 peer-reviewed journal articles and 40 book chapters in hematopathology. She received her PhD in biochemistry from the University of Miami, and earned her MD and completed her pathology residency at Washington University in St. Louis. She completed her hematopathology fellowship under Dr. Carl Kjeldsberg at the University of Utah.

Academic Locations

801-583-2787

560 Arapeen Drive
ARUP Executive Offices
Salt Lake City, UT  84108

Emma Eccles Jones Research Building

801-581-4390

15 North Medical Drive East
Pathology Administration, 1100
Salt Lake City, UT  84112

Board Certification and Academic Information

Academic Departments Pathology - Professor
Pediatrics - Adjunct Professor
Academic Divisions Clinical Pathology
Pediatric Administration
Board Certification American Board of Pathology (Sub: Anatomic Path)
American Board of Pathology (Sub: Hematology)

Education History

Fellowship University of Utah School of Medicine
Hematopathology
Fellow
Residency Washington University
Pathology
Resident
Internship Washington University
Pathology
Intern
Professional Medical Washington University
Medicine
M.D.
Doctoral Training University of Miami
Pathology
Ph.D.
Graduate Training San Francisco State University
Molecular Biology
M.A.
Graduate Training University of Arizona

Postbaccalaureate Studies
Undergraduate Colby College

B.A.
Undergraduate American College in Paris
Undergraduate College of Santa Fe

Selected Publications - Journal Articles

Journal Article

  1. 208 Chisholm KM, Mohlman J, Liew M, Termuhlen A, Cairo MS, Gross TG, Perkins SL, Miles RR (). IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children’s Oncology Group trials. Pediatr Blood Cancer.
  2. 207 Guan J, Wang R, Hasan S, Tao L, Wazir M, Jain A, Zhu X, Perkins S, Salama, M Chang C-C, Mori S (). Prognostic significance of the dynamic change of programmed death-ligand 1 expression in patients with multiple myeloma. Cureus, 11(2019), e4401.
  3. Cairo M, Auperin A, Perkins SL, Pinkerton R, Harrison L, Goldman S, Patte C (). Overall survival of children and adolescents with mature B-cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group. Br J Haematol, 182, 859-869.
  4. 205 Matynia AP, Perkins SL, Li D (). Lymphomatoid Granulomatosis in a 14-Year-Old Boy with Trisomy 21 and History of B-Lymphoblastic Leukemia/Lymphoma. Fetal Pediatr Pathol, 37, 7-14.
  5. Yandow SM, Van de Velde, SK, Siebert J, Perkins SL ().

    The Influence of Aspiration Volume on the Number of Osteoblastic Progenitors Obtained from Bone Marrow in Children. J Pediatr Orthop.

    . J Pediatr Orthop.
  6. Lee S, Day NS, Miles RR, Perkins SL, Lim MS, Ayello J, van de Ven C, Harrison L, El-Mallawany NK, Goldman S, Cairo MS (2017 May). Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. Br J Haematol, 177(4), 601-611.
  7. Paxton CN, OMalley DP, Bellizzi AM, Alkapalan D, Fedoriw Y, Hornick JL, Perkins SL, South ST, Andersen EF (). Genomic Alterations are Rare in Solitary Juvenile Xanthogranuloma and may Correlate with Staging in Disseminated Cases. Mod Pathol.
  8. Andersen EF, Paxton CN, OMalley DP, Louissaint, Jr A, Hornick JL, Griffin GK, Fedoriw Y, Kim YS, Weiss LM, Perkins SL, South ST (). Genomic Analysis of Follicular Dendritic Cell Sarcoma by Molecular Inversion Probe Array Reveals Tumor Suppressor-Driven Biology. Mod Pathol.
  9. Lee S, Luo W, Shah T, Yin C, OConnell T, Chung TH, Perkins SL, Miles RR, Ayello J, Morris E, Harrison L, van de Ven, C, Cairo M (). The effects of DLEU1 gene expression in Burkitt lymphoma (BL): Potential mechanism of chemoimmunotherapy resistance in BL. Oncotarget, 8, 27839-27853.
  10. Nussenzveig RH, Pham HT, Perkins SL, Prchal JT, Agarwal AM, Salama ME (2016). Increased frequency of co-existing JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2(V617F) allelic burden. Leuk Lymphoma, 57(6), 1429-35.
  11. Klinger M, Zheng J, Elenitoba-Johnson KS, Perkins SL, Faham M, Bahler DW (2016 May). Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. Leukemia, 30(5), 1055-61.
  12. OSuoji C, Welch JJ, Perkins SL, Smith LM, Weitzman S, Simko SJ, Galardy PJ, Bollard CM, Gross TG, Termuhlen AM (2016 May). Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1. Pediatr Blood Cancer, 63(5), 794-800.
  13. Sever C, Abbott CL, de Baca ME, Khoury JD, Perkins SL, Reichard KK, Taylor A, Terebelo HR, Colasacco C, Rumble RB, Thomas NE (2016 Sep). Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med, 140(9), 932-49.
  14. Gomez-Gelvez JC, Salama ME, Perkins SL, Leavitt M, Inamdar KV (2016 Apr). Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy. Am J Clin Pathol, 145(4), 514-23.
  15. Agarwal AM, Nussenzveig RH, Reading NS, Patel JL, Sangle N, Salama ME, Prchal JT, Perkins SL, Yaish HM, Christensen RD (2016 Sep). Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. Br J Haematol, 174(5), 806-14.
  16. Meyer JA, Zhou D, Mason CC, Downie JM, Rodic V, Abromowitch M, Wistinghausen B, Termuhlen AM, Angiolillo AL, Perkins SL, Barnette P, Schiffman JD, Miles RR (2016 Dec 13). Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.LID - 10.1002/pbc.26363 [doi]. (Epub ahead of print) Pediatr Blood Cancer.
  17. Burkhardt B, Mueller S, Khanam T, Perkins SL (). Current status and future directions of T-lymphoblastic lymphoma in children and adolescents. Br J Haematol, 173, 545-59.
  18. Sever C, Abbott CL, de Baca ME, Khoury JD, Perkins SL, Reichard KK, Taylor A, Terebelo HR, Colasacco C, Rumble RB, Thomas NE ().

    Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med. Epub 2/23/16.

    . Arch Pathol Lab Med.
  19. Klinger M, Zheng J, Elenitoba-Johnson K, Perkins SL, Faham M, Bahler D (). Next-Generation IgVH Sequencing CLL-Like Monoclonal B-Cell Lymphocytosis Reveals Frequent Oligoclonality and Ongoing Hypermutation. Leukemia, 30, 1055-61.
  20. Gomez-Gelvez JC, Salama ME, Jacobsen G, Perkins SL, Leavitt M, Inamdar KV ().

    The Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated with R-CHOP Chemotherapy

    . Am J Clin Pathol, 145, 512-23.
  21. Nussenzveig RH, Pham HT, Perkins SL, Prchal J, Agarwal A, Salama ME (). Increased frequency of coexisting JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2V617F allelic burden. Leuk Lymphoma, 57, 1429-35.
  22. OSuoji C, Welch J, Perkins SL, Smith LM, Weitzman S, Simko SJ, Galardy PJ, Termuhlen AM (). Rare Pediatric Non-Hodgkin Lymphomas: A report from Children’s Oncology Group study ANHL04B1. Pediatr Blood Cancer, 63, 794-800.
  23. Chen ZW, Perkins SL, Weiss RL, Bahler DW, Hussong JW, Salama ME (2015 Jan). A limited plasma cell flow cytometry panel with reflex CD138 immunohistochemistry is an optimal workflow process for evaluating plasma cell neoplasms in bone marrow specimens. Am J Clin Pathol, 143(1), 78-83.
  24. Li KD, Miles R, Tripp SR, Glenn MJ, Perkins SL, Salama M (2015 Apr). Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma. Am J Clin Pathol, 143(4), 598-604.
  25. Shiramizu B, Goldman S, Smith L, Agsalda-Garcia M, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Barth MJ, Mussolin L, Cairo MS (2015 Aug). Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report. Br J Haematol, 170(3), 367-71.
  26. Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS (2015 Jun 20). Revised International Pediatric Non-Hodgkin Lymphoma Staging System. J Clin Oncol, 33(18), 2112-8.
  27. Sandlund JT, Guillerman RP, Perkins SL, Pinkerton CR, Rosolen A, Patte C, Reiter A, Cairo MS (2015 Jun 20). International Pediatric Non-Hodgkin Lymphoma Response Criteria. J Clin Oncol, 33(18), 2106-11.
  28. Sandlund JT, Perkins SL (). Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches. Br J Haematol, 169(5), 631-46.
  29. Sandlund JT, Guillerman RP, Perkins SL, Pinkerton CR, Rosolen A, Patte C, Reiter A, Cairo MS (). International Pediatric Non-Hodgkin Lymphoma Response Criteria. J Clin Oncol, 33(18), 2106-11.
  30. Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS (). Revised International Pediatric Non-Hodgkin Lymphoma Staging System. J Clin Oncol, 33(18), 2112-8.
  31. Salama ME, Du S, Efimova O, Heikal NM, Wendlandt E, Toydemir RM, South S, Perkins SL, Hussong JW, Zhan F (2015 Feb). Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities. Leuk Lymphoma, 56(2), 426-33.
  32. Li K, Miles R, Tripp SR, Glenn MJ, Perkins SL, Salama M (). Clinicopathologic Evaluation of MYC Expression in Primary Mediastinal (Thymic) Large B-cell Lymphoma. Am J Clin Pathol, 143, 598-604.
  33. Minard-Colin V, Brugieres L, Reiter A, Cairo MS, Gross TG, Woesmann W, Burkhardt B, Sandlund JT, Williams D, Pillon M, Horibe K, Auperin A, Le Deley MC, Zimmerman M, Perkins SL, Raphael M, Lamant L, Klapper W, Mussolin L, Poirel HA, Macintyre E, Damm-Welk C, Rosolen A, Patte C (). Non-Hodgkin Lymphoma in Children and Adolescents: Progress through Effective Collaboration, Current Knowledge and Challenges Ahead. J Clin Oncol, 33(27), 2963-74.
  34. Chen ZW, Perkins SL, Weiss RL, Bahler DW, Hussong JW, Salama ME (). A limited plasma cell flow cytometry panel with reflex CD138 immunohistochemistry is an optimal workflow process for evaluating plasma cell neoplasms in bone marrow specimens. Am J Clin Pathol, 143, 78-83.
  35. Sangle NA, Schmidt RL, Patel JL, Medeiros LJ, Agarwal AM, Perkins SL, Salama ME (2014 Aug). Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm. Mod Pathol, 27(8), 1137-43.
  36. Alexander S, Kraveka JM, Weitzman S, Lowe E, Smith L, Lynch JC, Chang M, Kinney MC, Perkins SL, Laver J, Gross TG, Weinstein H (2014 Dec). Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group. Pediatr Blood Cancer, 61(12), 2236-42.
  37. Chen ZW, Kohan J, Perkins SL, Hussong JW, Salama ME (2014). Web-based oil immersion whole slide imaging increases efficiency and clinical team satisfaction in hematopathology tumor board. J Pathol Inform, 5(1), 41.
  38. Chen ZW, Kohan J, Perkins SL, Hussong JW, Salame ME (). Web-based oil immersion whole slide imaging increases efficiency and clinical team satisfaction in hematopathology tumor board. J Pathol Inform, 5, 41.
  39. Goldman S, Smith L, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Shiramizu B Barth M, Cairo MS (). Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children’s Oncology Group Report. Br J Haematol, 167(3), 394-401.
  40. Sangle N, Cook J, Perkins S, Teman CJ, Bahler D, Hickman K, Wilson A, Prchal J, Salama ME (2014 Oct). Myelofibrotic transformations of polycythemia vera and essential thrombocythemia are morphologically, biologically, and prognostically indistinguishable from primary myelofibrosis. Appl Immunohistochem Mol Morphol, 22(9), 663-8.
  41. Alexander S, Kraveka JM, Weitzman S, Lowe E, Smith L, Lynch JC, Chang M, Kinney MC, Perkins SL, Laver J, Gross TG, Weinstein H (). Advanced stage anaplastic large cell lymphoma in children and adolescents: Results of ANHL0131, a randomized Phase III Trial of APO versus a modified regimen with Vinblastine: A Report from the Children’s Oncology Group. Pediatr Blood Cancer, 61(12), 2236-42.
  42. Smock KJ, Perkins SL (). Thrombocytopenia: an update. Int Jnl Lab Hem. Int J Lab Hematol, 36, 269-278.
  43. Sangle N, Schmidt R, Patel J, Medeiros LF, Agarwal A, Perkins SL, Salama ME (). Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm. Mod Pathol, 27, 1137-43.
  44. Smock KJ, Agarwal AM, Lim MS, Tripp SR, Miles RR, Patel JL, Lones MA, Cairo MS, Perkins SL (). Expression of Notch1 and mTOR Pathway Proteins in Pediatric Lymphoblastic Lymphoma; A Children’s Oncology Group Report. Journal of Hematopathology, 7(1), 9-14.
  45. Gerrard M, Waxman IM, Sposto R, Auperin A, Perkins SL, Goldman S, Harrison L, Pinkerton R, McCarthy K, Raphael M, Patte C, Cairo MS (2013 Jan 10). Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy. Blood, 121(2), 278-85.
  46. Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, Bhagavathi S, Greiner TC, Weisenburger DD, Aoun P, Perkins SL, McKeithan TW, Inghirami G, Chan WC (2013 Sep 19). MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood, 122(12), 2083-92.
  47. Termuhlen AM, Smith LM, Perkins SL, Lones M, Finlay JL, Weinstein H, Gross TG, Abromowitch M (2013 Sep). Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group. Br J Haematol, 162(6), 792-801.
  48. Galardy PJ, Hochberg J, Perkins SL, Harrison L, Goldman S, Cairo MS (2013 Nov). Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report. Br J Haematol, 163(3), 365-72.
  49. Kikuchi K, Taniguchi E, Chen HI, Svalina MN, Abraham J, Huang ET, Nishijo K, Davis S, Louden C, Zarzabal LA, Recht O, Bajwa A, Berlow N, Suelves M, Perkins SL, Meltzer PS, Mansoor A, Michalek JE, Chen Y, Rubin BP, Keller C (2013 Nov 25). Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma. Skelet Muscle, 3(1), 27.
  50. Kikuchi K, Taniguchi E, Chen HH, Svalina MN, Abraham J, Huang ET, Nishijo K, Davis S, Louden C, Zarzabal LA, Recht O, Bajwa A, Berlow N, Suelves M, Perkins SL, Meltzer PS, Mansoor A, Michalek JE, Chen Y, Rubin BP, Keller C (). Rb1 Loss Modifies but Does Not Initiate Alveolar Rhabdomyosarcoma. Skeletal Muscle. In press 10/23/13. Skelet Muscle, 3(1), 27.
  51. Wagner LA, Wang S, Wayner EA, Christensen CJ, Perkins SL, Ward GW, Weiss RB, Dunn DM, Redd MJ, Spangrude GJ, Gleich GJ (). Developing and mature human granulocytes express ELP 6 in the cytoplasm. Hum Antibodies, 22(1-2), 21-9.
  52. Liu C, Iqbal J, Teryua-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang C, Hu X, Bhagavathi S, Greiner TC, Weisenburger DD, Aoun P, Perkins SL, McKeithan TW, Inghirami G, Chan WC (). microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood, 122(12), 2083-92.
  53. Galardy P, Hochberg J, Perkins SL, Harrison L, Goldman S, Cairo MS (). Rasburicase in the prevention of laboratory/clinical tumor lysis syndrome in children with advanced mature B-NHL: A Children’s Oncology Group Report. Br J Haematol, 163(3), 365-72.
  54. Barth J, Goldman S, Smith L, Perkins S, Shiramizu B, Gross TG, Harrison L, Sanger W, Geyer MB, Giulino L, Cairo MS (). Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: A Children’s Oncology Group (COG) Report. Br J Haematol, 162(5), 678-83.
  55. Gerrard M, Waxman IM, Sposto R, Auperin A, Perkins SL, Harrison L, Pinkerton R, McCarthy K, Raphael M, Patte C, Cairo, MS (). Outcome and pathological classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy. Blood, 121(2), 278-285.
  56. Termuhlen AM, Smith LM, Perkins SL, Lones M, Finlay JL, Weinstein H, Gross TG, Abromowitch M (). Disseminated lymphoblastic lymphoma in children and adolescents: Results of the COG A5971 Trial. A report from the Children’s Oncology Group. Br J Haematol, 162(6), 792-801.
  57. Lones MA, Raphael M, McCarthy K, Wotherspoon A, Terrier-Lacombe MJ, Ramsay AD, Maclennan K, Cairo MS, Gerrard M, Michon J, Patte C, Pinkerton R, Sender L, Auperin A, Sposto R, Weston C, Heerema NA, Sanger WG, von Allmen D, Perkins SL (2012 Jan). Primary follicular lymphoma of the testis in children and adolescents. J Pediatr Hematol Oncol, 34(1), 68-71.
  58. Cairo MS, Sposto R, Gerrard M, Auperin A, Goldman SC, Harrison L, Pinkerton R, Raphael M, McCarthy K, Perkins SL, Patte C (2012 Feb 01). Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (>/= 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study. J Clin Oncol, 30(4), 387-93.
  59. Nussenzveig RH, Burjanivova T, Salama ME, Ogilvie NW, Marcinek J, Plank L, Agarwal AM, Perkins SL, Prchal JT (2012 Dec). Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera. Leuk Lymphoma, 53(12), 2479-86.
  60. Leventaki V, Rodic V, Tripp SR, Bayerl MG, Perkins SL, Barnette P, Schiffman JD, Miles RR (2012 Sep). TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases. Br J Haematol, 158(6), 763-71.
  61. Gross TG, Orjuela MA, Perkins SL, Park JR, Lynch JC, Cairo MS, Smith LM, Hayashi RJ (2012 Nov). Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report. Am J Transplant, 12(11), 3069-75.
  62. El-Mallawany NK, Frazer JK, Van Vlierberghe P, Ferrando AA, Perkins S, Lim M, Chu Y, Cairo MS (2012 Apr). Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer J, 2(4), e65.
  63. Deffenbacher KE, Iqbal J, Sanger W, Shen Y, Lachel C, Liu Z, Liu Y, Lim MS, Perkins SL, Fu K, Smith L, Lynch J, Staudt LM, Rimsza LM, Jaffe E, Rosenwald A, Ott GK, Delabie J, Campo E, Gascoyne RD, Cairo MS, Weisenburger DD, Greiner TC, Gross TG, Chan WC (2012 Apr 19). Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood, 119(16), 3757-66.
  64. Sirdah M, Reading NS, Perkins SL, Shubair M, Aboud L, Prchal JT (2012 Apr 15). Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c.1311 C>T polymorphism among Palestinians at Gaza Strip. Blood Cells Mol Dis, 48(4), 203-8.
  65. Nussenzveig RH, Burjanivova T, Salama M, Ogilvie NW, Marcinek J, Plank L, Agarwal AM, Perkins SL, Prchal J ().

    Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: Identification of L611S alone and in cis with V617F in Polycythemia Vera

    . Leuk Lymphoma, (53), 2479-86.
  66. Termuhlen AM, Smith LM, Perkins SL, Lones M, Finlay JL, Weinstein H, Gross TG, Abromowitch M (2012 Dec 15). Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group. Pediatr Blood Cancer, 59(7), 1229-33.
  67. Patel JL, Smith LM, Anderson J, Abromowitch M, Campana D, Jacobsen J, Lones MA, Gross TG, Cairo MS, Perkins SL (2012 Nov). The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report. Br J Haematol, 159(4), 454-61.
  68. Patel JL, Smith LM, Anderson J, Abromowitch M, Campana D, Jacobsen J, Lones MA, Gross TG, Cairo MS, Perkins SL (). The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: A Children’s Oncology Group Report. Br J Haematol, (159), 454-61.
  69. Cairo M, Sposto R, Gerrard M, Auperin A, Perkins SL, Pinkerton R, McCarthy K, Raphael M, Harrison L, Goldman S, Platte C (). Overall survival of children and adolescents with mature B-cell non-Hodgkin lymphoma who relapsed or progressed during or after treatment with FAB/LMB 96. A report from the FAB/LMB 96 Study Group. J Clin Oncol, (30), 387-93.
  70. Leventaki V, Rodic V, Tripp SR, Bayerl MG, Perkins SL, Barnette P, Schiffman JD, Miles RR (). p53 pathway alterations in pediatric Burkitt lymphoma. Br J Haematol, (158), 763-771.
  71. Vanhille DL, Nussenzveig RH, Glezos C, Perkins SL, Agarwal AM (). Best practices for use of the Hemox Analyzer in the Clinical Laboratory: QC determination and choice of anticoagulant. Lab Hematol. In Press 5/15/12. Lab Hematol, (18), 17-19.
  72. Sirdah M, Reading NS, Vankayalapati H, Perkins SL, Shubair ME, Aboud L, Prchal JT (). Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Gaza Strip Palestinians. Blood Cells Mol Dis, (49), 152-8.
  73. Lones MA, Raphael M, McCarthy K, Wotherspoon A, Terrier-Lacombe M, Ramsay AD, MacLennan K, Cairo MS, Gerrard M, Michon J, Patte C, Pinkerton R, Sender L, Auperin A, Sposto R, Weston C, Heerema NA, Sanger WG, Perkins SL (). Primary follicular lymphoma of the testis in children and adolescents. J Pediatr Hematol Oncol, 34(1), 68-71.
  74. Cairo MS, Sposto R, Gerrard M, Auperin A, Goldman SC, Harrison L, Pinkerton CR, Raphael M, McCarthy K, Perkins SL, Patte C (). Advanced stage, elevated LDH and primary site, but not adolescent age (≥15 years), are associated with an increased risk of failure in children and adolescents with mature B-NHL: results of the FAB/LMB 96 study. J Clin Oncol, (30), 387-93.
  75. Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG, Sanmann JN, Althof PA, Sanger WG, Barnette P, Perkins SL, Miles RR (2011 Nov). Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br J Haematol, 155(4), 477-86.
  76. Kelly KM, Sposto R, Hutchinson R, Massey V, McCarten K, Perkins S, Lones M, Villaluna D, Weiner M (2011 Mar 3). BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group. Blood, 117(9), 2596-603.
  77. Sangle N, Perkins SL (). Core binding factor acture myeloid leukemia. Arch Pathol Lab Med, 135, 1504-1509.
  78. Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG, Sanmann JN, Althof PA, Sanger, WG, Barnette P, Perkins SL, Miles RR (). Genome Wide Copy Number Analysis of Paediatric Burkitt Lymphoma Using Formalin Fixed Tissues Reveals a Subset with Gain of Chromosome 13q and Corresponding miRNA Over Expression. Br J Haematol, (155), 477-486.
  79. Harris RE, Termuhlen AM, Smith LM, Lynch J, Henry MM, Perkins SL, Gross TG, Warkentin P, Vlachos A, Harrison L, Cairo MS (2011 Feb). Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of children's oncology group study A5962. Biol Blood Marrow Transplant, 17(2), 249-58.
  80. Teman CJ, Tripp SR, Perkins SL, Duncavage EJ (2011 May). Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Res, 35(5), 689-92.
  81. Perkins SL, Gross TG (2011 Apr 14). Pediatric indolent lymphoma-would less be better?LID - 10.1002/pbc.23152 [doi]. (Epub ahead of print) Pediatr Blood Cancer.
  82. Sangle NA, Agarwal AM, Smock KJ, Leavitt MO, Warnke R, Bahler DH, Perkins SL (). Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7. Appl Immunohistochem Mol Morphol, 19(6), 579-583.
  83. Kelly KM, Sposto R, Hutchinson R, Massey V, McCarten K, Perkins SL, Lones M, Villaluna D, Weiner M (). BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high risk Hodgkin lymphoma: A report from the Children’s Oncology Group CCG-59704 clinical trial. Blood, 117, 2596-603.
  84. Shiramizu B, Goldman S, Kusao I, Agsalda M, Lynch J, Harrison L, Morris E, Gross TG, Sanger W, Perkins SL, Cairo MS (). Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin Lymphoma: A Children’s Oncology Group Report. Br J Haematol, 153(6), 758-763.
  85. Harris RE, Termuhlen A, Henry MM, Perkins SL, Gross TG, Warkentin P, Vlachos A, Lynch J, Harrison L, Cairo MS (In Press). Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group Study A5962. Biol Blood Marrow Transplant, 17, 249-58.
  86. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, Heerema NA, Lones MA, Harrison L, Cairo MS, Sanger WG (2010 Feb). An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. Br J Haematol, 148(4), 600-10.
  87. Teman CJ, Wilson AR, Perkins SL, Hickman K, Prchal JT, Salama ME (2010 Jul). Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study. Leuk Res, 34(7), 871-6.
  88. Bradley KT, Arber DA, Brown MS, Chang CC, Coupland SE, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill MC, McClure SP, Medeiros LJ, Perkins SL, Hussong JW (2010 Mar). Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa. Arch Pathol Lab Med, 134(3), 336-40.
  89. Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill M, McClure SP, Medeiros LJ, Perkins SL (2010 Jun). Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms. Arch Pathol Lab Med, 134(6), e40-7.
  90. Hussain S, Foreman O, Perkins SL, Witzig TE, Miles RR, van Deursen J, Galardy PJ (2010 Sep). The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling. Leukemia, 24(9), 1641-55.
  91. Kumanovics A, Perkins SL, Gilbert H, Cessna MH, Augustine NH, Hill HR (2010 Nov). Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol, 30(6), 886-93.
  92. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JB, Lones MA, Cairo MS, Sanger WG (). Impact of 13q deletions as detected by fluorescence in situ hybridization on outcome in children and adolescents with Burkitt lymphoma: results from the Children's Cancer Group study CCG-5961. Br J Haematol, 4, 600-610.
  93. Harris RE, Termuhlen AM, Smith LM, Lynch J, Henry MM, Perkins SL, Gross TG, Warkentin P, Vlachos A, Harrison L, Cairo MS (). Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children’s Oncology Group Study A5962. Biol Blood Marrow Transplant, epub.
  94. Salama ME, Rajan Mariappan M, Inamdar K, Tripp SR, Perkins SL (). The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. Int J Surg Pathol, 18(2), 121-8.
  95. Salama ME, Rajan Mariappan M, Inamdar K, Tripp SR, Perkins SL (). The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. Int J Surg Pathol, 18(2), 121-8.
  96. Hussong JW, Arber DA, Bradley KT, Brown MS, Chang C, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill M, McClure SP, Medeiros LJ, Perkins SL (In Press). Protocol for the Examination of Specimens from Patients with Non-Hodgkin Lymphoma/Lymphoid Neoplasms. Arch Pathol Lab Med, 134, e40-47.
  97. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JB, Lones MA, Cairo MS, Sanger WG (epub 1/27/2010). An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. Br J Haematol.
  98. Miles RR, Afify Z, Yaish H, Perkins SL (In Press). CD56-Negative extranodal nasal type NK/T-cell lymphoma. Pediatr Blood Cancer, (55), 186-189.
  99. Teman CJ, Wilson AR, Perkins SL, Prchal JT, Salama ME (In Press). Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study. Leuk Res, 34(7), 871-6.
  100. Bradley KT, Arber DA, Brown MS, Chang C, Coupland SE, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill M, McClure SP, Medeiros LJ, Perkins SL, Hussong JW (3/2010). Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms of the Ocular Adnexa. Arch Pathol Lab Med, 134, 336-340.
  101. Gerrard M, Waxman I, Sposto R, Auperin A, Harrison L, Pinkerton R, Perkins SL, McCarthy K, Raphael M, Patte C, Cairo MS (2009 May 20). Association of primary mediastinal B-cell lymphoma (PMBL) in children (C) and adolescents (A) with a significantly inferior prognosis: Final results of the FAB/LMB 96 trial. J Clin Oncol, 27(15_suppl), 10001.
  102. Cairo MS, Sposto R, Gerrard M, Waxman I, Goldman S, Auperin A, Pinkerton R, Raphael M, McCarthy K, Perkins SL, Patte C (2009 May 20). Advanced stage, elevated LDH, primary sites, but not adolescent (A) age (>/= 15 years) as risk factors for disease progression in childhood (C) and adolescent (A) mature B-NHL: Report of the FAB/LMB 96 international trial. J Clin Oncol, 27(15_suppl), 10032.
  103. Frazer JK, Meeker ND, Rudner L, Bradley DF, Smith AC, Demarest B, Joshi D, Locke EE, Hutchinson SA, Tripp S, Perkins SL, Trede NS (2009 Oct). Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia, 23(10), 1825-35.
  104. Coustan-Smith E, Sandlund JT, Perkins SL, Chen H, Chang M, Abromowitch M, Campana D (2009 Jul 20). Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group. J Clin Oncol, 27(21), 3533-9.
  105. Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, Chang CC (2009 Mar). Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. Journal of Hematopathology, 2(1), 20-6.
  106. Hasserjian RP, Chen S, Perkins SL, de Leval L, Kinney MC, Barry TS, Said J, Lim MS, Finn WG, Medeiros LJ, Harris NL, OMalley DP (2009 Dec). Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol, 22(12), 1532-40.
  107. Coustan-Smith E, Sandlund JT, Perkins SL, Chen H, Chang M, Abromowitch M, Campana D (2009). Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: A report from The Children's Oncology Group. J Clin Oncol, 27, 3533-3539.
  108. Chang CC, Perkins SL (IN PRESS). Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. J Hematother, 2, 20-26.
  109. Lowe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, Abromowitch M (2009 Mar). Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941. Pediatr Blood Cancer, 52(3), 335-9.
  110. Poirel HA, Cairo MS, Heerema NA, Swansbury J, Auperin A, Launay E, Sanger WG, Talley P, Perkins SL, Raphael M, McCarthy K, Sposto R, Gerrard M, Bernheim A, Patte C (2009 Feb). Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia, 23(2), 323-31.
  111. Tward JD, Cachoeira CV, Salama ME, Lee RJ, Bowen G, Perkins SL, Glenn M, Confer M, Gaffney DK (2009 Jan-Feb). Survival and recurrence in nonmycosis fungoides primary cutaneous lymphoma. Cancer J, 15(1), 87-92.
  112. Abromowitch M, Sposto R, Perkins S, Zwick D, Siegel S, Finlay J, Cairo MS (2008 Oct). Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group. Br J Haematol, 143(2), 261-7.
  113. Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R, Lambilliote A, Sposto R, McCarthy K, Lacombe MJ, Perkins SL, Patte C (2008 Jun). Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Br J Haematol, 141(6), 840-7.
  114. Dunphy CH, OMalley DP, Cheng L, Fodrie TY, Perkins SL, Kaiser-Rogers K (2008 Sep). Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH. Journal of Hematopathology, 1(2), 77-84.
  115. Yang DT, Dunphy CH, Tripp SR, Lagoo AS, Perkins SL (2008 Mar). Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component. Am J Hematol, 83(3), 218-21.
  116. Miles RR, Raphael M, McCarthy K, Wotherspoon A, Lones MA, Terrier-Lacombe MJ, Patte C, Gerrard M, Auperin A, Sposto R, Davenport V, Cairo MS, Perkins SL (2008 Sep). Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatr Blood Cancer, 51(3), 369-74.
  117. Smock KJ, Nelson M, Tripp SR, Sanger WG, Abromowitch M, Cairo MS, Perkins SL (2008 Oct). Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group. Pediatr Blood Cancer, 51(4), 489-94.
  118. Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC (2008 Oct). The role of beta-catenin in chronic myeloproliferative disorders. Hum Pathol, 39(10), 1454-8.
  119. Dunphy CH, OMalley DP, Cheng L, Fodrie TY, Perkins SL, Kaiser-Rogers K (2008). Primary mediastinal B-cell lymphoma:  Detection of bcl-2 gene rearrangements by PCR analysis and FISH. Journal of Hematopathology, 1, 77-84.
  120. Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R Lambilliote A, Sposto R, McCathy K, Terrier Lacombe MJ, Perkins SL, Patte C (2008). Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma:  Results of the FAB/LMB 96 International Study. Br J Haematol, 141, 840-7.
  121. Smock KJ, Nelson M, Tripp SR, Sanger WG, Abromowitch M, Cairo MS, Perkins SL (Submitted). Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in-situ hybridization: A report from the Children's Oncology Group. Pediatr Blood Cancer, 51(4), 489-94.
  122. Yang DT, Dunphy CH, Tripp SR, Lagoo AS, Perkins SL (2007). Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component. Am J Hematol, 83, 218-221.
  123. Salama ME, Perkins SL, Mariappan MR (2007). Images in HIV/AIDS. Primary bone marrow presentation of Epstein-Barr virus-driven HIV-associated Hodgkin lymphoma. AIDS Read, 17(12), 604-5.
  124. Smock KJ, Yaish HM, Cairo MS, Lones MA, Willmore-Payne C, Perkins SL (2007). Mantle cell lymphoma presenting with unusual morphology in an adolescent female: a case report and review of the literature. Pediatr Dev Pathol, 10(5), 403-8.
  125. Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, Weston C, Raphael M, Perkins SL, McCarthy K, Cairo MS (2007 Apr 1). Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood, 109(7), 2773-80.
  126. Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, Weston C, Perkins SL, Raphael M, McCarthy K, Patte C (2007 Apr 1). Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood, 109(7), 2736-43.
  127. Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch M, Kersey J, Bergeron S, Cairo MS, Sanger WG (2007 Jan 1). Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet, 172(1), 1-11.
  128. Wada DA, Perkins SL, Tripp S, Coffin CM, Florell SR (2007 Feb). Human herpesvirus 8 and iron staining are useful in differentiating Kaposi sarcoma from interstitial granuloma annulare. Am J Clin Pathol, 127(2), 263-70.
  129. Perkins SL, Reddy VB, Reichard KK, Thompsen MA, Dunphy CH (2007 Jun). Recommended curriculum for teaching hematopathology to subspecialty hematopathology fellows. Am J Clin Pathol, 127(6), 962-76.
  130. Dunphy CH, OMalley DP, Perkins SL, Chang CC (2007 Jun). Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias. Appl Immunohistochem Mol Morphol, 15(2), 154-9.
  131. Smock KJ, Perkins SL, Bahler DW (2007 Jun). Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment. Arch Pathol Lab Med, 131(6), 951-5.
  132. Hsieh PP, Olsen RJ, Omalley DP, Konoplev SN, Hussong JW, Dunphy CH, Perkins SL, Cheng L, Lin P, Chang CC (2007 Sep). The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders. Mod Pathol, 20(9), 929-35.
  133. Miles RR, Cairo MS, Satwani P, Zwick DL, Lones MA, Sposto R, Abromovitch M, Tripp S, Angiolillo AL, Roman E, Davenport V, Perkins SL (2007 Aug). Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report. Br J Haematol, 138(4), 506-12.
  134. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, Cordon-Cardo C, Parsons R, Zuniga-Pflucker JC, Dominguez M, Ferrando AA (2007 Oct). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med, 13(10), 1203-10.
  135. Cooney-Qualter E, Krailo M, Angiolillo A, Fawwaz RA, Wiseman G, Harrison L, Kohl V, Adamson PC, Ayello J, Vande Ven C, Perkins SL, Cairo MS (2007 Sep 15). A Phase I Study of 90Yttrium-Ibritumomab-Tiuxetan in Children and Adolescents with Relapsed/Refractory CD20-Positive Non Hodgkin's Lymphoma: A Children's Oncology Group Study. Clin Cancer Res, 13(18), 5652s-60s.
  136. She R, Rawlins M, Mohl R, Perkins SL, Hill HR, Litwin CM (2007). Comparison of immunofluorescence antibady testing and two enzyme immunoassays in the serologic diagnosis of malaria. J Travel Med, 14, 1-7.
  137. Wada DA, Bowen AR, Perkins SL (2006). Sezary Syndrome with large cell transformation. ASCP CheckSample Series- Hematology, H-306.
  138. Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, Min DJ (2006 Aug). Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer, 47(2), 130-40.
  139. Perkins SL, Allen R (2006 May). Childhood physical abuse and differential development of paranormal belief systems. J Nerv Ment Dis, 194(5), 349-55.
  140. Florell SR, Cessna M, Lundell RB, Boucher KM, Bowen GM, Harris RM, Petersen MJ, Zone JJ, Tripp S, Perkins SL (2006 May). Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol, 125(5), 727-36.
  141. Rowe LR, Willmore-Payne C, Tripp SR, Perkins SL, Bentz JS (2006 Jun). Tumor cell nuclei extraction from paraffin-embedded lymphoid tissue for fluorescence in situ hybridization. Appl Immunohistochem Mol Morphol, 14(2), 220-4.
  142. Pysher TJ, Bach PR, Geaghan SM, Hamilton MS, Laposata M, Lockitch G, Brugnara C, Coffin CM, Pasquali M, Rinaldo P, Roberts WL, Rutledge JC, Ashwood ER, Blaylock RC, Campos JM, Goldsmith B, Jones PM, Lim M, Meikle AW, Perkins SL, Perry DA, Petti CA, Rogers BB, Steele PE, Weiss RL, Woods G (2006 Jul). Teaching pediatric laboratory medicine to pathology residents. Arch Pathol Lab Med, 130(7), 1031-8.
  143. Lones MA, Heerema NA, Le Beau MM, Perkins SL, Kadin ME, Kjeldsberg CR, Sposto R, Meadows A, Siegel S, Buckley J, Finlay J, Abromowitch M, Cairo MS, Sanger WG (2006 Dec). Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet, 171(2), 89-96.
  144. Wada DA, Bowen AR, Perkins SL (2006). Sézary Syndrome with large cell transofrmation. ASCP CheckSample Series.
  145. Lone MA, Raphael M, Auperin A, Perkins SL, Wotherspoon A, Terrier-Lacombe MJ, Cairo MS, Gerrard M, Patte C, McCarthy K (2006). Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality. J Pediatr Hematol Oncol, 28, 568-574.
  146. Yang D, Greenwood J, Hartung L, Hill S, Perkins SL, Bahler DW (2005). Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations. Am J Clin Pathol, 124, 930-936.
  147. Lundell R, Hill S, Greenwood J, Perkins SL, Bahler D (2005). T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol, 124, 937-946.
  148. Perkins SL, Pickering D, Lowe EJ, Zwick D, Abromovich M, Davenport G, Cairo MS, Sanger WG (2005). Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescence in situ hybridization: a genetic and pathologic correlation: A report from the Children's Oncology Group. Br J Haematol, 131, 624-627.
  149. Teitill MA, Lones MA, Perkins SL, Sanger WG, Cairo MS, Said JW (2005). TCL1 expression and Epstein-Barr status in pediatric Burkitt lymphoma. Am J Clin Pathol, 124, 569-575.
  150. OMalley DP, Kim YS, Perkins SL, Baldridge L, Juliar BE, Orazi A (2005 Dec). Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders. Mod Pathol, 18(12), 1550-61.
  151. Novoa-Takara L, Perkins SL, Qi D, Shidham VB, Vesole DH, Hariharan S, Luo Y, Ewton A, Chang CC (2005 Jan). Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation. Am J Clin Pathol, 123(1), 104-12.
  152. Cessna MH, Hartung L, Tripp S, Perkins SL, Bahler DW (2005 Jan). Hairy cell leukemia variant: fact or fiction. Am J Clin Pathol, 123(1), 132-8.
  153. Cairo MS, Raetz E, Lim MS, Davenport V, Perkins SL (2005 Nov). Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future. Pediatr Blood Cancer, 45(6), 753-69.
  154. Frost M, Newell J, Lones MA, Tripp SR, Cairo MS, Perkins SL (2004 Mar). Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Clin Pathol, 121(3), 384-92.
  155. Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL (2004 Apr). Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol, 28(4), 464-70.
  156. Lones MA, Sanger WG, Le Beau MM, Heerema NA, Sposto R, Perkins SL, Buckley J, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Finlay J, Bergeron S, Cairo MS (2004 Mar). Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08. J Pediatr Hematol Oncol, 26(3), 169-78.
  157. Shiramizu B, Perkins SL, Bergeron S, Lones M, Kelly K, Weiner M, Cairo MS (2004 Dec). Assessing immunoglobulin heavy chain rearrangements in pediatric CD20-positive and CD20-negative classic Hodgkin's disease. Clin Lymphoma, 5(3), 184-9.
  158. Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, Viskochil DH (2003). Malignant peripheral nerve sheath tumor (MPNST): A comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1 (NF1)-related lesions. Am J Surg Pathol, 27, 1337-45.
  159. Perkins SL, Lones MA, Davenport V, Cairo MS (2003). B-cell Non-Hodgkin lymphoma in children and adolescents: surface antigen expression and clinical implications for future targeted bioimmune therapy: A Children's Cancer Group report. Clin Adv Hematol Oncol, 1, 314-7.
  160. Raetz E, Perkins S, Davenport G, Cairo MS (2003). B Large-cell lymphoma in children and adolescents. Cancer Treat Rev, 29, 91-8.
  161. Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL (2003 Feb). Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Arch Pathol Lab Med, 127(2), 208-12.
  162. Sabesan V, Cairo MS, Lones MA, Perkins SL, Morris E, Sposto R, Van De Ven C, Shiramizu B (2003 Feb). Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers. J Pediatr Hematol Oncol, 25(2), 109-13.
  163. Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL (2003 Feb). Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol, 120(4), 660-70.
  164. Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z, Tripp S, Shami PJ, Wang LY, Coupland RW, Buckstein R, Perez-Ordonez B, Perkins SL, Dube ID, Lim MS (2003 Jun 10). Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A, 100(12), 7259-64.
  165. Abbott RT, Tripp S, Perkins SL, Elenitoba-Johnson KS, Lim MS (2003 Jun). Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray. Mod Pathol, 16(6), 607-12.
  166. Meda BA, Frost M, Newell J, Bohling SD, Huebner-Chan DR, Perkins SL, Lim MS, Medeiros LJ, Elenitoba-Johnson KS (2003 Jul). BCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissue. Am J Surg Pathol, 27(7), 888-94.
  167. Jasionowski TM, Hartung L, Greenwood JH, Perkins SL, Bahler DW (2003 Aug). Analysis of CD10+ hairy cell leukemia. Am J Clin Pathol, 120(2), 228-35.
  168. Chang CC, Osipov V, Wheaton S, Tripp S, Perkins SL (2003 Sep). Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers. A sequential spectrum of morphologic evolution in lymphoid hyperplasia. Am J Clin Pathol, 120(3), 322-6.
  169. Newton DL, Perkins SL (2002). Plasma Cell Leukemia. ASCP CheckSample Series- Hematology, 42, H-02-4 (H-271).
  170. Baer KE, Perkins S (2002). Sezary syndrome. ASCP CheckSample Series- Hematology, 42, H-02-01 (H-268).
  171. Frost M, Perkins SL (2002). Acute erythroid leukemia. ASCP CheckSample Series- Hematology, 42, H-02-3 (H-270).
  172. Liu T, Raetz E, Moos PJ, Perkins SL, Bruggers CS, Smith F, Carroll WL (2002 Feb). Diversity of the apoptotic response to chemotherapy in childhood leukemia. Leukemia, 16(2), 223-32.
  173. Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL, Cairo MS (2002 May 1). Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol, 20(9), 2293-301.
  174. Kelly KM, Hutchinson RJ, Sposto R, Weiner MA, Lones MA, Perkins SL, Massey V (2002). Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704. Ann Oncol, 13 Suppl 1, 107-11.
  175. Zhou H, Perkins SL, Tripp S, Hussong JW, Coffin CM (2002 Sep-Oct). Expression of apoptosis-related antigens, Fas, bcl-2, and p53, and Mib-1 proliferation index in the hypoplastic thymus of DiGeorge syndrome. Pediatr Dev Pathol, 5(5), 465-71.
  176. Raetz EA, Perkins SL, Carlson MA, Schooler KP, Carroll WL, Virshup DM (2002 Sep). The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas. Am J Pathol, 161(3), 875-83.
  177. Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, Daines C, Coffin CM (2002 Sep). Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol, 15(9), 931-8.
  178. Lim MS, Adamson A, Lin Z, Perez-Ordonez B, Jordan RC, Tripp S, Perkins SL, Elenitoba-Johnson KS (2002 Oct 15). Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index. Blood, 100(8), 2950-6.
  179. Coffin CM, Patel A, Perkins SL, Griffin CA, Elenitoba-Johnson KSJ, Perlman EJ, Griffin CA (2001). ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol, 14, 569-76.
  180. Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, Coffin CM (2001 Sep). Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol, 25(9), 1150-7.
  181. Dunphy CH, Perkins SL (2001 Apr). Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia. Arch Path, 125(4), 513-8.
  182. Dunphy CH, Perkins SL (2001 May). Mantle cell leukemia, prolymphocytoid type: a rarely described form. Leuk Lymphoma, 41(5-6), 683-7.
  183. Fang J, Hussong JW, Perkins SL, Yu GH, Sack MJ, Wood BL (2000 Jun). Diagnosis and classification of lymphoma based on cytospin preparations: a comparison of hematopathologists and cytopathologists. Diagn Cytopathol, 22(6), 336-41.
  184. Coleman LW, Perkins SL, Bronstein IB, Holden JA (2000 Jun). Expression of DNA toposiomerase I and DNA topoisomerase II-alpha in testicular seminomas. Hum Pathol, 31(6), 728-33.
  185. Hussong JW, Perkins SL, Huff V, McDonald JM, Pysher TJ, Beckwith JB, Coffin CM (2000 Nov-Dec). Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis. Pediatr Dev Pathol, 3(6), 561-7.
  186. Clohisy DR, Perkins SL, Ramnaraine MLR (2000). Cellular mechanisms of tumor osteolysis. Clin Orthop Relat Res, 373, 104-112.
  187. Dauterman JF, Perkins SL (2000). Cold agglutinin disorders. ASCP CheckSample Series- Hematology, 40, HP-00-5 (HP-43).
  188. Monnin KA, Perkins SL (2000). B-cell non-Hodgkin's lymphoma in children. ASCP CheckSample Series- Hematology, 40, HP-00-4 (HP-42).
  189. Marty J, Perkins SL (2000). Aplastic anemia. ASCP CheckSample Series- Hematology, 40, H-1.
  190. Lones MA, Perkins SL, Sposto R, Kadin ME, Kjeldsberg CR, Wilson JF, Cairo MS (2000 Nov 15). Large-cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol, 18(22), 3845-53.
  191. Lones MA, Auperin A, Raphael M, McCarthy K, Perkins SL, MacLennan KA, Ramsay A, Wotherspoon A, Gerrard M, Cairo MS, Patte C (2000 Jan). Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the revised European-American Lymphoma Classification. Ann Oncol, 11(1), 47-51.
  192. Chang CC, Liu YC, Cleveland RP, Perkins SL (2000 Apr). Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. Am J Clin Pathol, 113(4), 512-8.
  193. Lones MA, Cairo MS, Perkins SL (2000 May 15). T-cell-rich large B-cell lymphoma in children and adolescents: a clinicopathologic report of six cases from the Children's Cancer Group Study CCG-5961. Cancer, 88(10), 2378-86.
  194. Perkins SL (2000 Jul-Aug). Work-up and diagnosis of pediatric non-Hodgkin's lymphomas. Pediatr Dev Pathol, 3(4), 374-90.
  195. Batanian JR, Dunphy CH, Richart JM, Petruska PJ, Perkins SL (2000 Jul 15). Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma. Cancer Genet Cytogenet, 120(2), 136-40.
  196. Chang CC, Eshoa C, Kampalath B, Shidham VB, Perkins S (2000 Nov). Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow. Am J Clin Pathol, 114(5), 807-11.
  197. Hussong JW, Brown M, Perkins SL, Dehner LP, Coffin CM (1999 Mar). Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol, 12(3), 279-86.
  198. Goldsby RE, Perkins SL, Virshup DM, Brothman AR, Bruggers CS (1999 May-Jun). Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia. J Pediatr Hematol Oncol, 21(3), 240-3.
  199. Bruggers CS, Fults D, Perkins SL, Coffin CM, Carroll WL (1999). Expression of apoptotic genes in brain tumors. J Pediatr Hematol Oncol, 21, 19-25.
  200. Bills A, Green W, Tsodivik A, Perkins S, Carey M, Peterson F, Kelley L (1999). A statistical model for evaluation of minimal residual disease in peripheral blood stem cell collections from breast cancer patients. Cytotherapy, 1, 389-99.
  201. Adamson A, Perkins S, Brambilla E, Tripp S, Holden J, Guinee D (1999). C-myc and cyclin D1 expression in diffuse avelolar damage: potential roles in proliferation and apotosis. Hum Pathol, 30, 1050-7.
  202. Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G (1999 Jan). Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol, 111(1), 111-6.
  203. Qi DY, Perkins SL, Kling SJ, Russell RG (1999 Mar 1). Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis. J Cell Biochem, 72(3), 387-95.
  204. Brown MS, Holden JA, Rahn MP, Perkins SL (1998 Jan). Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease. Am J Clin Pathol, 109(1), 39-44.
  205. Bruggers CS, Tai KF, Murdock T, Sivak L, Le K, Perkins SL, Coffin CM, Carroll WL (1998 Jan-Feb). Expression of the c-Myc protein in childhood medulloblastoma. J Pediatr Hematol Oncol, 20(1), 18-25.
  206. Guinee DG Jr, Perkins SL, Travis WD, Holden JA, Tripp SR, Koss MN (1998 Sep). Proliferation and cellular phenotype in lymphomatoid granulomatosis: implications of a higher proliferation index in B cells. Am J Surg Pathol, 22(9), 1093-100.
  207. Rubin J, Biskobing DM, Jadhav L, Fan D, Nanes MS, Perkins S, Fan X (1998 Mar). Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells. Endocrinology, 139(3), 1006-12.
  208. Wheaton S, Netser J, Guinee D, Rahn M, Perkins S (1998 Aug). Bcl-2 and bax protein expression in indolent versus aggressive B-cell non-Hodgkin's lymphomas. Hum Pathol, 29(8), 820-5.
  209. Bauman ME, Holden JA, Brown KA, Harker WG, Perkins SL (1997 Mar). Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas. Mod Pathol, 10(3), 168-75.
  210. Woodward M, Perkins SL (1997). Systemic mast cell disease. ASCP CheckSample Series- Hematology, 39, HP97-1 (HP-21).
  211. Brown M, Perkins SL (1997). T-cell prolymphocytic leukemia. ASCP CheckSample Series- Hematology, 39, CH97-1 (CH-19).
  212. Mathewson RC, Kjeldsberg CR, Perkins SL (1997 Nov-Dec). Detection of terminal deoxynucleotidyl transferase (TdT) in nonhematopoietic small round cell tumors of children. Pediatr Pathol Lab Med, 17(6), 835-44.
  213. Perkins SL, Sarraj E, Kling SJ, Kohan DE (1997 Mar). Endothelin stimulates osteoblastic production of IL-6 but not macrophage colony-stimulating factor. Am J Physiol, 272(3 Pt 1), E461-8.
  214. White WL, Zhang YL, Shelby J, Trautman MS, Perkins SL, Hammond EH, Shaddy RE (1997 Feb). Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy. J Heart Lung Transplant, 16(2), 250-5.
  215. Dunphy CH, Wheaton SE, Perkins SL (1997 Aug). CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod Pathol, 10(8), 818-22.
  216. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW (1996 Feb). Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases. Arthritis Rheum, 39(2), 325-9.
  217. Henderson GS, Brown KA, Perkins SL, Abbott TM, Clayton F (1996 Apr). bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma. Mod Pathol, 9(4), 430-8.
  218. Brieske ME, Rahn MP, Perkins SL (1996). Basophilic Leukemia: Report of a case and review of the literature. Lab Hematol, 2, 16-21.
  219. Perkins SL (1996). Immunophenotypic analysis of CD5 positivity in paraffin-embedded tissues. Still waiting for an effective diagnostic antibody. Am J Clin Pathol, 106, 273-74.
  220. Holden JA, Perkins SL, Snow GW, Kjeldsberg CR (1995 Jul). Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas. Am J Clin Pathol, 104(1), 54-9.
  221. ODonnell LR, Alder SL, Balis UR, Perkins SL, Kjeldsberg CR (1995). Immunohistochemical reference ranges for B lymphocytes in bone marrow biopsy paraffin sections. Endocrinology, 104, 517-523.
  222. Piira T, Perkins SL, Anderson JR, Meadows AT, Chilcote RR, Kadin M, Kjeldsberg CR (1995 Jul-Aug). Primary mediastinal large cell lymphoma in children: a report from the Childrens Cancer Group. Pediatr Pathol Lab Med, 15(4), 561-70.
  223. Kahn A, Gibbons R, Perkins S, Gazit D (1995 Apr). Age-related bone loss. A hypothesis and initial assessment in mice. Clin Orthop Relat Res, (313), 69-75.
  224. Perkins SL, Kling SJ, Ross FP, Teitelbaum SL (1995 Dec). 1,25 dihydroxyvitamin D3 stimulates differentiation of committed murine bone marrow-derived macrophage precursor cells. Endocrinology, 136(12), 5643-50.
  225. Perkins SL, Kling SJ (1995 Dec). Local concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation. Am J Physiol, 269(6 Pt 1), E1024-30.
  226. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, Braylan RC, Kjeldsberg CR (1994 Mar 15). Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood, 83(6), 1626-31.
  227. Holden JA, Snow GW, Perkins SL, Jolles CJ, Kjeldsberg CR (1994 Oct). Immunohistochemical staining for DNA topoisomerase II in frozen and formalin-fixed paraffin-embedded human tissues. Mod Pathol, 7(8), 829-34.
  228. Perkins SL, Gibbons R, Kling S, Kahn AJ (1994 Jan-Feb). Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone, 15(1), 65-72.
  229. Lacey DL, Erdmann JM, Shima M, Kling S, Matayoshi A, Ohara J, Perkins SL (1994 Jul). Interleukin 4 enhances osteoblast macrophage colony-stimulating factor, but not interleukin 6, production. Calcif Tissue Int, 55(1), 21-8.
  230. Segal GH, Kjeldsberg CR, Smith GP, Perkins SL (1994 Sep). CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases. Am J Clin Pathol, 102(3), 292-8.
  231. Gibbons R, Ross FP, Perkins SL, Lacey DL, Martin J, Ebner R, Teitelbaum SL, Kahn AJ (1994 Apr). Interleukin-4 enhances murine bone marrow macrophage M-CSF receptor expression by a posttranscriptional mechanism. Lymphokine Cytokine Res, 13(2), 85-92.
  232. Piira TA, Ries K, Kjeldsberg CR, Perkins SL (1994). Anaplastic large-cell lymphoma presenting primarily in bone in a patient with AIDS. Hematol Pathol, 8(3), 111-6.
  233. Smith GP, Perkins SL, Segal GH, Kjeldsberg CR (1994 Oct). T-cell lymphocytosis associated with invasive thymomas. Am J Clin Pathol, 102(4), 447-53.
  234. Smith GP, Perkins SL, Kjeldsberg CR (1993). Thrombotic thrombocytopenia purpura. ASCP CheckSample Series- Hematology, 35, H93-10 (H257).
  235. Snow GW, Perkins SL, Kjeldsberg CR (1993). Acute lymphoblastic leukemia presenting with arthritis and renal failure. ASCP CheckSample Series- Hematology, 35, H93-7 (H254).
  236. Schleusener JT, Perkins SL, Kjeldsberg CR (1993). Burkitt's lymphoma presenting in leukemic phase. ASCP CheckSample Series- Hematology, 35, H93-6 (H253).
  237. Kohan DE, Perkins SL, Terreros DA (1993 Jan). Immune complex glomerulonephritis with unusual microfibrillar deposits associated with primary bone marrow lymphoma. Am J Kidney Dis, 21(1), 47-51.
  238. Schreiber S, Perkins SL, Teitelbaum SL, Chappel J, Stahl PD, Blum JS (1993 Nov 1). Regulation of mouse bone marrow macrophage mannose receptor expression and activation by prostaglandin E and IFN-gamma. J Immunol, 151(9), 4973-81.
  239. Liechty KW, Schibler KR, Ohls RK, Perkins SL, Christensen RD (1993). The failure of newborn mice infected with Escherichia coli to accelerate neutrophil production correlates with their failure to increase transcripts for granulocyte colony-stimulating factor and interleukin-6. Biol Neonate, 64(5), 331-40.
  240. Kohan DE, Hughes AK, Perkins SL (1992 Jun 15). Characterization of endothelin receptors in the inner medullary collecting duct of the rat. J Biol Chem, 267(17), 12336-40.
  241. Smith GP, Perkins SL, Kjeldsberg CR (1991). Hereditary myeloperoxidase deficiency. ASCP CheckSample Series- Hematology, 35, H93-5 (H252).
  242. Perkins SL, Dabbas B, Kjeldsberg CR (1991). Chronic myelomonocytic leukemia. ASCP CheckSample Series- Hematology, 33, H-91-9 (H236).
  243. Dabbas B, Perkins SL, Kjeldsberg CR (1991). Acute biphenotypic leukemia. ASCP CheckSample Series- Hematology, 33, H91-7 (H-234).
  244. Perkins SL, Dabbas B, Kjeldsberg CR (1991). Polycythemia vera evolving into acute myelogenous leukemia. ASCP CheckSample Series- Hematology, 33, H91-6 (H-233).
  245. Perkins SL, Teitelbaum SL (1991 Jan). 1,25-Dihydroxyvitamin D3 modulates colony-stimulating factor-1 receptor binding by murine bone marrow macrophage precursors. Endocrinology, 128(1), 303-11.
  246. Schreiber S, Blum JS, Stenson WF, MacDermott RP, Stahl PD, Teitelbaum SL, Perkins SL (1991 Mar 1). Monomeric IgG2a promotes maturation of bone-marrow macrophages and expression of the mannose receptor. Proc Natl Acad Sci U S A, 88(5), 1616-20.
  247. Schreiber S, Stenson WF, MacDermott RP, Chappel JC, Teitelbaum SL, Perkins SL (1991 Aug 15). Aggregated bovine IgG inhibits mannose receptor expression of murine bone marrow-derived macrophages via activation. J Immunol, 147(4), 1377-82.
  248. Perkins SL, Link DC, Kling S, Ley TJ, Teitelbaum SL (1991 Nov). 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of the PLB-985 leukemic line and promotes c-fgr mRNA expression. J Leukoc Biol, 50(5), 427-33.
  249. Schreiber S, Blum JS, Chappel JC, Stenson WF, Stahl PD, Teitelbaum SL, Perkins SL (1990 Apr). Prostaglandin E specifically upregulates the expression of the mannose-receptor on mouse bone marrow-derived macrophages. Cell Regul, 1(5), 403-13.
  250. Perkins SL, Yunis AA (1986 Jun). Pattern of colony-stimulating activity in HL-60 cells after phorbol-ester-induced differentiation. Exp Hematol, 14(5), 401-5.
  251. Perkins SL, Andreotti PE, Sinha SK, Wu MC, Yunis AA (1984 Nov). Human myeloid leukemic cell (HL-60) autostimulator: relationship to colony-stimulating factor. Cancer Res, 44(11), 5169-75.
  252. Perkins SL, Ledin SF, Stubbs JD (1982 Apr 15). Linkage of the isoprenoid biosynthetic pathway with induction of DNA synthesis in mouse lymphocytes. Effects of compactin on mitogen-induced lymphocytes in serum-free medium. Biochim Biophys Acta, 711(1), 83-9.

Review

  1. Burkhardt B, Mueller S, Khanam T, Perkins SL (2016 May). Current status and future directions of T-lymphoblastic lymphoma in children and adolescents. [Review]. Br J Haematol, 173(4), 545-59.
  2. Sandlund JT, Perkins SL (2015 Jun). Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches. [Review]. Br J Haematol, 169(5), 631-46.
  3. Minard-Colin V, Brugieres L, Reiter A, Cairo MS, Gross TG, Woessmann W, Burkhardt B, Sandlund JT, Williams D, Pillon M, Horibe K, Auperin A, Le Deley MC, Zimmerman M, Perkins SL, Raphael M, Lamant L, Klapper W, Mussolin L, Poirel HA, Macintyre E, Damm-Welk C, Rosolen A, Patte C (2015 Sep 20). Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead. [Review]. J Clin Oncol, 33(27), 2963-74.
  4. Smock KJ, Perkins SL (2014 Jun). Thrombocytopenia: an update. [Review]. Int J Lab Hematol, 36(3), 269-78.
  5. Sangle NA, Perkins SL (2011 Nov). Core-binding factor acute myeloid leukemia. [Review]. Arch Pathol Lab Med, 135(11), 1504-9.
  6. Wallentine JC, Perkins SL, Tripp SR, Bruggman RD, Bayerl MG (2009 Feb). Diffuse large B-cell lymphoma with coexpression of CD3 in a pediatric patient: a case report, review of the literature, and tissue microarray study. [Review]. J Pediatr Hematol Oncol, 31(2), 124-7.
  7. Reddy KS, Perkins SL (2004 Dec). Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms. [Review]. Am J Clin Pathol, 122 Suppl, S3-18.
  8. Perkins SL (2004 Dec). Pediatric red cell disorders and pure red cell aplasia. [Review]. Am J Clin Pathol, 122 Suppl, S70-86.
  9. Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL (2003 Jan). Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. [Review]. Am J Hematol, 72(1), 53-63.
  10. Gardner LJ, Polski JM, Evans HL, Perkins SL, Dunphy CH (2001 Aug). CD30 expression in follicular lymphoma. [Review]. Arch Path, 125(8), 1036-41.
  11. Eshoa C, Perkins S, Kampalath B, Shidham V, Juckett M, Chang CC (2001 Jun). Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. [Review]. Am J Clin Pathol, 115(6), 862-7.
  12. Lones MA, Sanger W, Perkins SL, Medeiros LJ (2000 Sep). Anaplastic large cell lymphoma arising in bone: report of a case of the monomorphic variant with the t(2;5)(p23;q35) translocation. [Review]. Arch Path, 124(9), 1339-43.
  13. Perkins SL, Segal GH, Kjeldsberg CR (1995 Nov). Classification of non-Hodgkin's lymphomas in children. [Review]. Semin Diagn Pathol, 12(4), 303-13.
  14. Segal GH, Perkins SL, Kjeldsberg CR (1995 Nov). Benign lymphadenopathies in children and adolescents. [Review]. Semin Diagn Pathol, 12(4), 288-302.
  15. Perkins SL, Segal GH, Kjeldsberg CR (1995 Nov). Work-up of lymphadenopathy in children. [Review]. Semin Diagn Pathol, 12(4), 284-7.
  16. Perkins SL, Kjeldsberg CR (1993 Apr). Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues. [Review]. Am J Clin Pathol, 99(4), 362-73.

Book Chapter

  1. Hussong JW, Sorensen E, Perkins SL, Couturier MR, Grenache DG, Lamb AN, Straseski JA, Cohen MG (). Laboratory Methods. In JW Hussong, CR Kjeldsberg (Eds.), Body Fluid Analysis (2nd, pp. 3-30). Chicago, IL: ASCP Press.
  2. Perkins SL (). Cerebrospinal Fluid. Body Fluids, 2nd ed. In C Kjeldsberg and J Hussong (Eds.), Body Fluid Analysis (2nd, pp. 45-88). Chicago, IL: ASCP Press.
  3. Smock KJ, Perkins SL (). Examination of the Blood and Bone Marrow. In JP Greer, DA Arber, B Glader, AF List, RT Means, Jr., F Paraskevas, GM Rodgers (Eds.), Wintrobe’s Clinical Hematology (Thirteenth, pp. 1 - 18). Philadelphia, PA: Lippincott Williams & Williams.
  4. Perkins SL, Yaish HM, Salama ME (). Donath-Landsteiner Hemolytic Anemia (Paroxysmal Cold Hemoglobinuria). In G Gulati, J Filicko-O’Hara, JR Krause (Eds.), Case Studies in Hematology and Coagulation (pp. 50-52). Chicago, IL: ASCP.
  5. Perkins SL, Yaish HM, Salama ME ().

    Anemia Associated with Pyruvate Kinase Deficiency

    . In G Gulati, J Filicko-O’Hara, JR Krause (Eds.), Case Studies in Hematology and Coagulation (pp. 36-38). Chicago, IL: ASCP.
  6. Gross TG, Perkins SL (In Press). Malignant non-Hodgkin lymphomas in children. In PA Pizzo, DG Poplack (Eds.), Principles and Practice of Pediatric Oncology (6th, pp. 633-682). Philadelphia, PA: Lippincott Williams & Wilkins.
  7. Perkins SL (In press). Pediatric mature T-cell and NK-cell non-Hodgkin lymphomas. In M. Proytcheva (Ed.), Diagnostic Pediatric Hematopathology (pp. 429-464). New York, NY: Cambridge University Press.
  8. Perkins SL (In press). Pediatric mature B-cell non-Hodgkin lymphomas. In M. Proytcheva (Ed.), Diagnostic Pediatric Hematopathology (pp. 395-428). New York, NY: Cambridge University Press.
  9. Perkins SL, McKenna R (2010). Precursor lymphoid neoplasms. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 2, pp. 691-719). Chicago, IL: ASCP Press.
  10. Perkins SL, McKenna RW (2010). Myelodysplastic syndromes. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 2, pp. 547-582). Chicago, IL: ASCP Press.
  11. Perkins SL, Vardiman J (2010). Myelodysplastic/myeloproliferative neoplasms. In CR Kjeldsberg, SL Perkins (Eds.), Practical DIagnosis of Hematologic Disorders (5th, 2, pp. 535-546). Chicago, IL: ASCP Press.
  12. Salama M, Perkins SL (2010). Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 2, pp. 527-534). Chicago, IL: ASCP Press.
  13. Perkins SL, Salama M, Vardiman J (2010). Chronic eosinophilic leukemia. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 2, pp. 501-508). Chicago, IL: ASCP Press.
  14. Perkins SL (2010). Paroxysmal nocturnal hemoglobinuria. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 141-148). Chicago, IL: ASCP Press.
  15. Perkins SL (2010). Disorders of hemoglobin synthesis. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 123-140). Chicago, IL: ASCP Press.
  16. Perkins SL (2010). Glucose-6-phosphate dehydrogenase deficiency. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 113-122). Chicago, IL: ASCP Press.
  17. Perkins SL (2010). Hereditary erythrocyte disorders due to deficiencies of the glycolytic pathway. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 105-112). Chicago, IL: ASCP Press.
  18. Perkins SL (2010). Hereditary erythrocyte membrane defects. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 93-104). Chicago, IL: ASCP Press.
  19. Perkins SL (2010). Accelerated erythrocyte turnover. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 79-92). Chicago, IL: ASCP Press.
  20. Perkins SL (2010). Hypochromic, microcytic anemias. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 17-30). Chicago, IL: ASCP Press.
  21. Perkins SL (2010). Diagnosis of anemia. In CR Kjeldsberg, SL Perkins (Eds.), Practical Diagnosis of Hematologic Disorders (5th, 1, pp. 1-16). Chicago, IL: ASCP Press.
  22. Perkins S, Qualman S (IN PRESS). Pathological evaluation of childhood cancer. In Carroll W, Finlay JL (Eds.), Cancer in Children & Adolescents (pp. 45-68). Sudbury, MA: Jones and Bartlett.
  23. Perkins SL (2008). Aplastic anemia including pure red cell aplasia, congenital dyserythropoietic anemia, and paroxymal nocturnal hemoglobinuria. In D Harmening (Ed.), Clinical Hematology and Fundamentals of Hemostasis (fourth, pp. 156-175). Philadelphia, PA: F.A. Davis.
  24. Perkins SL (2008). Principles of hematologic and bone marrow examination. In JR Greer, J Foerester, JN Lukens, GM Rodgers, F Paraskevas, B Gladers (Eds.), Wintrobe's Clinical Hematology (Twelfth, pp. 1-20). Baltimore, MD: Williams and Wilkins.
  25. Perkins SL (2007). Hematopoietic system. Bone marrow, peripheral blood and lymphomas. In E Gibert-Barness, R Kapur and L Oligny (Eds.), Potters Pathology of the Infant and Fetus (pp. 1453-1514). Philadelphia, PA: Elsevier.
  26. Perkins SL, Morris S (2007). Biology and pathology of pediatric non-Hodgkins lymphoma. In Weinstein M Lind and M Hudson (Eds.), Pediatric Lymphomas (pp. 91-127). New York, NY: Springer-Verlag.
  27. Perkins SL (2006). In Alan HB Wu (Ed.), Tietz Clinical Guide to Laboratory Tests (4th edition). St. Louis, MO: Saunders.
  28. Cairo MS, Raetz E, Perkins SL (2006). Non-Hodgkin lymphoma in children. In DW Kufe, RE Pollock, RR Werchselbaum, RC Bast Jr., TS Gansler, JF Holland, E Frei III (Eds.), Cancer 7 Medicine (pp. 1962-1975). Hamilton, London: BC Decker Inc.
  29. Perkins SL (2006). Paryoxysmal nocturnal hemoglobinuria. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 141-148). Chicago, IL: ASCP Press.
  30. Perkins SL (2006). Disorders of hemoglobin synthesis. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 123-140). Chicago, IL: ASCP Press.
  31. Perkins SL (2006). Hereditary disorders of the hexose monophosphate shunt pathway: glucose-6-phosphate dehydrogenase deficiency. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 113-122). Chicago, IL: ASCP Press.
  32. Perkins SL (2006). Hereditary erythrocyte disorders due to deficiencies of the glycolytic pathway. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 105-112). Chicago, IL: ASCP Press.
  33. Perkins SL (2006). Hereditary erythrocyte membrane defects. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 93-104). Chicago, IL: ASCP Press.
  34. Perkins SL (2006). Accelerated erythrocyte turnover. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 79-92). Chicago, IL: ASCP Press.
  35. Perkins SL (2006). Hypochromic, microcytic anemias. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 17-30). Chicago, IL: ASCP Press.
  36. Perkins SL (2006). Diagnosis of anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (4th Edition, pp. 1-16). Chicago, IL: ASCP Press.
  37. Perkins SL (2004). Principles of hematologic and bone marrow examination. In Greer JR, Forester J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (Eds.), Wintrobe's Clinical Hematology (11th Edition, pp. 3-26). New York, NY: Williams and Wilkins.
  38. Cairo MS, Raetz E, Perkins SL (2003). Non-Hodgkin Lymphoma in Children. In Kufe DW, Pollock RE, Weichselbaum RR, Bast Jr RC, Gansler TS, Holland JF, Frei III E (Eds.), Cancer 6 Medicine (pp. 2337-48). Hamilton, London: B. C. Decker.
  39. Chang C, Wittwer C, Perkins S (2002). Measurement of MDR1 Gene Expression by Real Time Quantitative RT-PCR Using LightCyclerTM. In Wittwer C (Ed.), LightCycler Application Manual.
  40. Perkins SL (2002). Aplastic anemia (including pure red cell aplasia and congenital dyserythropoietic anemia). In Harmening D (Ed.), Clinical Hematology and Fundamentals of Hemostasis (4th Edition, pp. 129-40). Philadelphia, PA: F. A. Davis.
  41. Perkins SL (2001). Blood and bone marrow pathology in infections, systemic diseases and metastatic neoplasms and following therapy. In Collins RD, Swerdlow SH (Eds.), Pediatric Hematopathology (pp. 157-68). New York, NY: Churchill Livingston.
  42. Perkins SL (2001). Myeloproliferative and myeloproliferative disorders. In Collins RD, Swerdlow SH (Eds.), Pediatric Hematopathology (pp. 147-56). New York, NY: Churchill Livingston.
  43. Perkins SL (2001). Disorders of hematopoiesis. In Collins RD, Swerdlow SH (Eds.), Pediatric Hematopathology (pp. 105-39). New York, NY: Churchill Livingston.
  44. Perkins SL, Hussong JW (2001). Red Blood Cells. In Jones S (Ed.), Clinical Laboratory Pearls (pp. 61-98). Philadelphia, PA: Lippincott Williams & Wilkins.
  45. Perkins SL (2000). Extrinsic hemolytic anemis: general concepts and tranfusion reactions. In C. Kjeldsberg (Ed.), Practical Diagnosis of Hematologic Disorders (Third, pp. 183-194). Chicago, IL: ASCP Press.
  46. Perkins SL (2000). Paroxysmal nocturnal hemoglobinuria. In C. Kjeldsberg (Ed.), Practical Diagnosis of Hematologic Disorders (Third, pp. 171-182). Chicago, IL: ASCP Press.
  47. Perkins SL (2000). Disorders of hemoglobin synthesis. In C. Kjeldsberg (Ed.), Practical Diagnosis of Hematologic Disorders (Third, pp. 145-170). Chicago, IL: ASCP Press.
  48. Perkins SL (2000). Hereditary disorders of the hexose monophosphate shunt pathway. In C. Kjeldsberg (Ed.), Practical Diagnosis of Hematologic Disorders (Third, pp. 131-144). Chicago, IL: ASCP Press.
  49. Cairo MS, Perkins S (2000). Non-Hodgkin's lymphoma in children. In Bast RC, Kufe DW, Pollack RE, Weilshelbaum RR, Hollan JF, Frei E (Eds.), Cancer Med (5th Edition, pp. 2162-7). Hamilton, Ontario: B. C. Decker.
  50. Perkins SL (2000). Autoimmune hemolytic anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (3rd Edition, pp. 219-38). Chicago, IL: ASCP Press.
  51. Perkins SL (2000). Drug-related extrinsic hemolytic anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (3rd Edition, pp. 207-18). Chicago, IL: ASCP Press.
  52. Perkins SL (2000). Extrinsic hemolytic anemia: fetomaternal incompatibility. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (3rd Edition, pp. 195-206). Chicago, IL: ASCP Press.
  53. Perkins SL (2000). Hereditary erythrocyte membrane defects. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (3rd Edition, pp. 111-20). Chicago, IL: ASCP Press.
  54. Perkins SL (2000). Accelerated erythrocyte turnover. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (3rd Edition, pp. 95-110). Chicago, IL: ASCP Press.
  55. Perkins SL (2000). Diagnosis of Anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (3rd Edition, pp. 3-22). Chicago, IL: ASCP Press.
  56. Perkins SL (1999). Principles of hematologic and bone marrow examination. In Lee GR, Forester J, Greer J, Lukens J, Rodgers G, Paraskevas F (Eds.), Wintrobe's Clinical Hematology (10th Edition, pp. 9-35). Baltimore, MD: Williams and Wilkins.
  57. Perkins SL (1995). Aplastic anemia (including pure red cell aplasia and congenital dyserythropoietic anemia). In Harmening D (Ed.), Clinical Hematology and Fundamentals of Hemostasis (3rd Edition, pp. 135-45). Philadelphia, PA: F. A. Davis.
  58. Perkins SL (1995). Hypersplenism. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 345-53). Chicago, IL: ASCP Press.
  59. Perkins SL (1995). Autoimmune hemolytic anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 207-23). Chicago, IL: ASCP Press.
  60. Perkins SL (1995). Drug-related extrinsic hemolytic anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 195-206). Chicago, IL: ASCP Press.
  61. Perkins SL (1995). Extrinsic hemolytic anemia: fetomaternal incompatibility. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 183-94). Chicago, IL: ASCP Press.
  62. Perkins SL (1995). Extrinsic hemolytic anemia: general concepts and transfusion reactions. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 171-82). Chicago, IL: ASCP Press.
  63. Perkins SL (1995). Paryoxysmal nocturnal hemoglobinuria. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 163-70). Chicago, IL: ASCP Press.
  64. Perkins SL (1995). Disorders of hemoglobin synthesis. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 138-62). Chicago, IL: ASCP Press.
  65. Perkins SL (1995). Hereditary disorders of the hexose monophosphate shunt pathway: glucose-6-phosphate dehydrogenase deficiency. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 127-37). Chicago, IL: ASCP Press.
  66. Perkins SL (1995). Hereditary erythrocyte disorders due to deficiencies of the glycolytic pathway. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 119-26). Chicago, IL: ASCP Press.
  67. Perkins SL (1995). Hereditary erythrocyte membrane defects. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 103-18). Chicago, IL: ASCP Press.
  68. Perkins SL (1995). Accelerated erythrocyte turnover. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 93-102). Chicago, IL: ASCP Press.
  69. Perkins SL (1995). Hypochromic, microcytic anemias. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 25-38). Chicago, IL: ASCP Press.
  70. Perkins SL (1995). Diagnosis of anemia. In Kjeldsberg CR (Ed.), Practical Diagnosis of Hematologic Disorders (2nd Edition, pp. 3-24). Chicago, IL: ASCP Press.

Conference Proceedings

  1. Lones MA, Raphael M, Perkins SL, Wotherspoon A, Auperin A, Terrier-Lacombe MJ, Sposto R, Weston C, Gerrard M, Patte C, Cairo MS, McCarthy K (2006 Sep). Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality. Utah Special Educator, United States, 28(9), 568-74.

Case Report

  1. Sangle NA, Miles RR, Kelley TW, Perkins SL (2014 Nov-Dec). Aberrant expression of multiple T antigens: CD4, CD5, and CD8 on diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol, 22(10), e45-8.
  2. Sangle NA, Agarwal AM, Smock KJ, Leavitt MO, Warnke R, Bahler D, Perkins SL (2011 Dec). Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7. Appl Immunohistochem Mol Morphol, 19(6), 579-83.
  3. Miles RR, Afify Z, Yaish H, Perkins SL (2010 Jul 15). CD56-negative extranodal nasal type NK/T-cell lymphoma. Pediatr Blood Cancer, 55(1), 186-9.
  4. Salama ME, Parham DM, Perkins SL, Bahler DW, Ellison DA (2008 Nov-Dec). Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study. Pediatr Dev Pathol, 11(6), 443-9.
  5. Smock KJ, Yaish HM, Cairo MS, Lones MA, Willmore-Payne C, Perkins SL (2007 Sep-Oct). Mantle cell lymphoma presenting with unusual morphology in an adolescent female: a case report and review of the literature. Pediatr Dev Pathol, 10(5), 403-8.
  6. Perkins SL, Han DP, Gonder JR, Beaumont PE, Colev G (2005 Dec). Dynamic atypical optic nerve coloboma associated with transient macular detachment. Arch Ophthalmol, 123(12), 1750-4.
  7. Perkins SL, Han DP, Gonder JR, Colev G, Beaumont PE (2005). Dynamic atypical optic nerve coloboma associated with transient macular detachment. Trans Am Ophthalmol Soc, 103, 116-23; discussuin 123-5.
  8. Brieske ME, Rahn MP, Perkins SL (1996). Basophilic Leukemia: Report of a case and review of the literature. Lab Hematol, 2, 16-21.

Editorial

  1. Perkins SL (2006 May). Saluting the canadian society of clinical chemists. Clin Biochem, 39(5), 421-2.
  2. Perkins SL (1996 Sep). Immunophenotypic analysis of CD5 positivity in paraffin-embedded tissues. Still waiting for an effective diagnostic antibody. Am J Clin Pathol, 106(3), 273-4.

Letter

  1. Goldman S, Smith L, Anderson JR, Perkins S, Harrison L, Geyer MB, Gross TG, Weinstein H, Bergeron S, Shiramizu B, Sanger W, Barth M, Zhi J, Cairo MS (2013 Apr). Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report [Letter to the editor]. Leukemia, 27(5), 1174-7.
  2. Chang CC, Cleveland RP, Perkins SL (2002 Apr). CD10 expression and survival [Letter to the editor]. Am J Clin Pathol, 117(4), 660-1; author reply 661-2.

Abstract

  1. Leventaki V, Agarwal AM, Perkins SL, Salama ME (In Press). Clonal relationship between concominant B-chronic lymphocytic leukemia and multiple myeloma by interphase fluorescent in sity hybridization: a case report and review of the literature [Abstract]. Histopathology, 53, 231 A.
  2. Shiramizu B, Perkins SL, Bergeron S, Lones M, Kelly K, Weiner M, Cairo M (2003). IgH rearrangements in pediatric CD20+ classic Hodgkin Disease Cases by PCR [Abstract]. J Pediatr Oncol, 25.
  3. Abbott R, Tripp S, Perkins SL, Elenitoba-Johnson KSJ, Lim MS (2002). Analysis of the PI-3 kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray [Abstract]. Lab Invest.
  4. Perkins SL, Lones MA, Davenport G, Cairo MS (2001). B-cell lymphoma/leukemia (BCLL) in children and adolescents central phenotype results from Children's Cancer Group study (CCG)-5961 and implications for future targeted bio-immune therapy (TBIT). Presented, International Society of Pediatric Oncology [Abstract]. Med Pediatr Oncol, 37(3), 172.
  5. Newell J, Perkins SL (2001). Comparative immunohistochemistry of pediatric Burkitt's lymphoma and diffuse large B-cell lymphoma [Abstract]. Mod Pathol, 14, 214A.
  6. Eschoa C, Perkins S, Bunyi-Teopengco E, Schultz C, Kampalath B, Chivukula M, Chang C (2001). Expression of p53 and EBV-LMP correlates with survival in primary central nervous system diffuse large B-cell lymphoma (CNS-DLBCL) [Abstract]. Mod Pathol, 14, 162A.
  7. Bunyi-Teopengco E, Perkins S, Kampalath B, Shidham VB, Chang C (2001). CD30 expression in granulocytic sarcoma [Abstract]. Mod Pathol, 14, 156A.
  8. Adamson A, Lin Z, Perez-Ordonez B, Jordan R, Tripp S, Perkisn S, Lim M (2001). Expression of SKP2, a p27 ubiquitin ligase in malignant lymphoma: correlation with p27 and proliferation index [Abstract]. Mod Pathol, 14, 154A.
  9. Coffin CM, Cessna MH, Perkins S, Tripp S, Daines C, Zhou H (2001). Expression of ALK-1 and p80 in inflammatory myofibroblastic tumor (IMT) and its mimics: A study of 135 cases [Abstract]. Mod Pathol, 14, 10A.
  10. Cessna M, Coffin C, Perkins S, Tripp S, Layfield L, Daines C, Zhou H (2001). Myogenin (MYOG) and MyoD1(MD1) expression in rhabdomyosarcoma (RMS) and spindle cell mimics: A study of 135 cases [Abstract]. Mod Pathol, 14, 10A.
  11. Zhou H, Perkins S, Hussong J, Coffin CM (2001). Expression of apoptosis-related antigens, FAS, BCL-2 and p53 on hypoplastic thymus in DiGeorge syndrome [Abstract]. Mod Pathol, 14, 9A.
  12. Lones MA, Cairo MS, Perkins SL (2000). T-cell-rich large B-cell lymphoma in children and adolescents: a clinicopathologic report of six cases from Children's Cancer Group Study CCG-5961 Treatment of Mature B-cell Leukemia/Lymphoma [Abstract]. Mod Pathol, 13, 204A.
  13. Hussong JW, Zwick D, Lones M, Greenwood J, Bruggers C, Raetz E, Perkins SL (2000). Correlation of white cell count (WCC), immunophenotype (IMP) and cytogenetic results with outcome in patients with infantile B-cell acute lymphoblastic leukemia [Abstract]. Mod Pathol, 13, 204A.
  14. Meda BA, Perkins SL, Hussong JW (2000). Increased angiogenesis associated with progression of chronic phase chronic myelogenous leukemia (CML-CP) to CML in accelerated phase or blast crisis (CML-AC/BC) [Abstract]. Mod Pathol, 13, 157A.
  15. Meda BA, Bohling SD, Perkins SL, Medieros LJ, Elenitoba-Johnson KSJ (2000). BCL-2 is consistently expressed in hyperplastic splenic marginal zones: A potential pitfall in the diagnosis of low grade B-cell lymphomas involving the spleen [Abstract]. Mod Pathol, 13, 156A.
  16. Chang C, Guinee D, Koss M, Perkins S (2000). The immunohistochemical profile of neoplastic B-cells and background T-cells in pulmonary lymphomatoid granulomatosis is similar to that of T-cell rich B-cell lymphoma [Abstract]. Mod Pathol, 13, 145A.
  17. Brown MS, Smith LM, Holden JA, Tripp S, Perkins SL (2000). Assessment of proliferation and apoptosis in Hodgkin's lymphoma: correlation with clinical outcome [Abstract]. Mod Pathol, 13, 144A.
  18. Coffin CM, Hussong J, Perkins S Griffin CA, Perlman EJ (2000). ALK and p80 expression in inflammatory myoblastic tumor (IMT) [Abstract]. Mod Pathol, 13, 8A.
  19. Lones M, Cairo M, Sposto R, Perkins S (1999). T-cell rich large B-cell lymphoma (TCRLBCL) in children: report of four cases from the Children's Cancer Study Group Study CCG-5961 [Abstract]. Ann Oncol, 10(Suppl 3), 121.
  20. Chang C, Perkins S, Witwer C (1999). Measurement of MDR1 gene expression by real time quantitative RT-PCR [Abstract]. Hum Pathol, 12, 190A.
  21. Carey M, Perkins S, Hussong J (1999). Immunohistochemical investigation of pediatric large cell lymphomas [Abstract]. Hum Pathol, 12, 178A.
  22. Chang C, Perkins S (1999). Expression of c-MYC and P53 correlates with clinical stage and outcome in diffuse large B-cell lymphomas [Abstract]. Hum Pathol, 12, 143A.
  23. Roepke J, Hussong J, Perkins S (1998). Proliferation and apototic markers in childhood Burkitt's lymphoma [Abstract]. Hum Pathol, 11, 169A.
  24. Perkins SL, Mu H-H, Kling SJ (1997). NFkB and NFIL-6 regulation of IL-6 synthesis is altered in aging mice [Abstract]. J Bone Min Res, 12(Suppl 1), S435.
  25. Rubin J, Biskobing DM, Jandav L, Nanes MS, Perkins S, Fan X (1997). Dexamethasone promotes expression of membrane bound macrophage colony stimulating factor [Abstract]. J Bone Min Res, 12(Suppl 1), S191.
  26. Brown M, Holden J, Rahn M, Perkins S (1997). Immunohistochemical staining for topoisomerase IIa in Hodgkin's disease [Abstract]. Mod Pathol, 10, 119A.
  27. Dunphy CH, Wheaton S, Perkins SL (1997). CD23 expression in transformed small lymphocytic leukemias/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma [Abstract]. Mod Pathol, 10, 124A.
  28. Netser J, Bauman M, Perkins S, Segal G, Kjeldsberg C (1997). Immunophenotypic characteristics of marginal zone lymphoma with a comprehensive paraffin-reactive antibody panel [Abstract]. Mod Pathol, 10, 131A.
  29. Wheaton S, Rahn M, Perkins S (1997). BCL-2 immunostaining demonstrates the spectrum of mantle B-cell and T-cell ingression in progressive transformation of germinal centers [Abstract]. Mod Pathol, 10, 136A.
  30. Netser J, Wheaton S, Guinee D, Perkins SL (1997). BAX protein expression in non-Hodgkin's lymphoma [Abstract]. Mod Pathol, 10, 131A.
  31. Kling SJ, Perkins SL (1996). Stromal cells from aging mice have dysregulated production of cytokines influencing osteoclastogenesis [Abstract]. J Bone Miner Res, 11, S167.
  32. Shaddy R, White W, Zhang L, Trautman M, Perkins S, Hammond E, Shelby J (1996). Myocardial apoptosis in a heterotropic murine heart transplant model of chronic rejection and graft vasculopathy [Abstract]. J Heart Lung Transplant, 15, S97.
  33. Mathewson RC, Kjeldsberg CR, Pappin A, Perkins SL (1996). Detection of TdT in non-hematopoietic small round cell tumors [Abstract]. Mod Pathol, 9, 151A.
  34. Bauman M, Holden J, Borwn K, Harker G, Perkins S (1996). Immunohistochemical staining of DNA Topoisomerase IIb in non-Hodgkin's lymphoma [Abstract]. Mod Pathol, 9, 107A.
  35. Perkins SL, Kling SJ, Ross FP, Teitelbaum SL (1995). 1,25 Dihydroxyvitamin D3 stimulates differentiation of murine bone marrow-derived macrophages [Abstract]. J Bone Miner Res, 10, S388.
  36. Sarraj E, Kling SJ, Kohan DE, Perkins SL (1995). Endothelins stimulate interleukin-6 but not M-CSF synthesis in the MC3T3-E1 osteoblast cell line and primary osteoblast cultures [Abstract]. J Bone Miner Res, 10, S302.
  37. Henderson GR, Brown K, Abbott T, Perkins SL, Clayton F (1995). BCL-2 expression is down-regulated in atypical endometrial hyperplasia and adenocarcinoma [Abstract]. Mod Pathol, 8, 90A.
  38. Alder SL, ODonnell LR, Balis UJ, Perkins SL, Kjeldsberg CR (1995). Immmunohistochemical reference ranges for B lymphocytes in bone marrow paraffin sections [Abstract]. Mod Pathol, 8, 105A.
  39. Perkins SL, Kling SR (1994). Age-associated variations in macrophage colony stimulating factor receptor expression may lead to increased osteoclast precursor pools [Abstract]. J Bone Miner Res, 9, S243.
  40. Gibbons R, Perkins SL, Hansen J, Kahn AJ (1993). Age-related changes in the monocytic/osteoclastic pathway in old mice [Abstract]. J Bone Miner Res, 8, S379.
  41. Perkins SL, Kling SR (1993). Macrophage colony stimulating factor concentrations are an important determinant in terminal in vitro osteoclast formation [Abstract]. J Bone Miner Res, 8, S390.
  42. Perkins SL, Kling SR (1993). Transforming growth factor b increases macrophage colony stimulating factor receptor expression in early bone marrow osteoclast precursor cells [Abstract]. J Bone Miner Res, 8, S121.
  43. Migden MR, Kling S, Araneo BA, Perkins SL, Trautman MS (1993). Interleukin-10 expression in murine bone marrow macrophages [Abstract]. West Soc Clin Res.
  44. Lacey D, Erdman J, Shima M, Ohara J, Kling S, Perkins S (1992). Interleukin 4 enhances osteoblast M-CSF but not IL-6 production [Abstract]. J Bone Miner Res, 7, S138.
  45. Gibbons R, Kling S, Kahn A, Perkins S (1992). Aging mice have increased bone marrow osteoclast precursors and in vitro osteoclast formation [Abstract]. J Bone Miner Res, 7, S103.
  46. Gibbons R, Ross P, Perkins S, Martin J, Teitelbaum S, Kahn A (1992). Interleukin-4 enhances CSF-1 receptor expression in monocytic cells by a post-translational mechanism [Abstract]. J Bone Miner Res, 7, S263.
  47. Perkins SL, Schreiber S, Blum J, Chappel J, Stenson WF, Stahl PD, Teitelbaum SL (1990). Prostaglandin E promotes bone marrow macrophage differentiation [Abstract]. American Society for Bone and Mineral Research.
  48. Perkins SL, Teitelbaum SL (1989). Vitamin D modulates expression of the CSF-1 receptor throughout macrophage differentiation [Abstract]. American Society for Bone and Mineral Research.
  49. Perkins SL, Link DC, Ley TJ, Teitelbaum SL (1989). Vitamin D-induced differentiation of the human promyelocytic cell line PLB-985 promotes c-fgr proto-oncogene expression but not respiratory burst capacity [Abstract]. American Society for Bone and Mineral Research.
  50. Perkins SL, Teitelbaum SL (1988). Vitamin D-induced differentiation of early osteoclast precursor cells [Abstract]. American Society for Gravitational and Space Biology.
  51. Perkins SL, Sinha SK, Yunis AA (1983). Phorbol ester induces production of colony-stimulating factor in HL-60 cells [Abstract]. Clin Res, 31, 509a.
  52. Perkins SL, Wu MC, Yunis AA (1982). The role of autostimulator and colony-stimulating factor in HL-60 cells [Abstract]. Clin Res, 30, 507A.

Video/Film/CD/Web/Podcast

  1. Yang DT, Perkins SL (2007). Intravascular large B-cell lymphoma. Society for Hematopathology. Case of the Quarter [Web]. Available: http://socforheme.org/caseqtr.htm.

Global Impact

Education History

Undergraduate American College in Paris

Site Links

  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • The Imagine Perfect Care Program

Helpful Links

  • Referring Providers
  • Find an Interpreter
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2018 University of Utah Health